MongoDB (NASDAQ: MDB) delivered a 51.5% earnings surprise Monday, but four factors beyond the beat drove shares up 14.4% after hours. First, the CEO transition shocked markets. Chirantan “CJ” Desai ...

MongoDB is set to report Q3 2026 earnings next week, and expectations are high after the stellar Q2 report this summer. Despite recent momentum, MDB faces persistent GAAP profitability issues, ...

This week: $16.8 million private placement offering for Paulex Bio, a biopharmaceutical company dedicated to sourcing, developing, and commercializing novel therapeutics for the treatment of diabetes.

The Common Principles for Tracking Nature Finance consist of definitions, guidelines and a standardized list of eligible activities that allow for consistent tracking of MDB financial flows supporting ...

MDB Capital Holdings (NASDAQ:MDBH) presented its second-quarter 2025 update on August 27, outlining strategic shifts amid significant financial headwinds. The company’s stock closed at $3.45, ...

MongoDB (NASDAQ: MDB), a leading database management provider, recently reported strong Q2 results that surpassed analyst expectations. The company also increased its full-year earnings forecast by 22 ...

Launched private offering for Paulex Bio, a company developing a transformational oral medication designed to eliminate the root cause of diabetes. Announced our next IPO and filed S-1 for Buda Juice, ...

Atlas revenue grew 26% YoY in Q1, now 72% of total — trajectory and consumption cadence are key into Q2 Management lifted FY26 revenue guide to $2.25–$2.29B and operating margin midpoint to 12%, ...

MongoDB MDB and Oracle ORCL are two leading names in the database market, but they’re built on very different foundations. MongoDB is a developer-first, cloud-native NoSQL platform optimized for ...

MongoDB (NASDAQ: MDB), a prominent database management firm, recently reported impressive Q1 results that greatly surpassed analyst predictions. The company reported adjusted earnings of $1.00 per ...

Even under extremely bullish DCF assumptions, MongoDB, Inc.'s intrinsic value falls short of current price, indicating little upside and stretched valuation. MDB benefits from AI in later phases; ...